GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Other Stockholders Equity

Veritas In Silico (TSE:130A) Other Stockholders Equity : 円0.0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Other Stockholders Equity?

Veritas In Silico's Other Stockholders Equity for the quarter that ended in Dec. 2024 was 円0.0 Mil.


Veritas In Silico Other Stockholders Equity Historical Data

The historical data trend for Veritas In Silico's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Other Stockholders Equity Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
- - - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial - - - - -

Veritas In Silico Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Veritas In Silico Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines